Accuray Incorporated (ARAY)
USD 1.55
(0.98%)
USD 1.55
(0.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 468.62 Million USD | -2.21% |
| 2023 | 479.21 Million USD | 1.35% |
| 2022 | 472.84 Million USD | -1.51% |
| 2021 | 480.09 Million USD | -2.04% |
| 2020 | 490.07 Million USD | 11.84% |
| 2019 | 438.18 Million USD | 15.7% |
| 2018 | 378.72 Million USD | -6.82% |
| 2017 | 406.46 Million USD | -13.34% |
| 2016 | 469.03 Million USD | -0.2% |
| 2015 | 469.97 Million USD | -5.09% |
| 2014 | 495.18 Million USD | 4.05% |
| 2013 | 475.92 Million USD | 0.58% |
| 2012 | 473.17 Million USD | 3.81% |
| 2011 | 455.78 Million USD | 73.18% |
| 2010 | 263.18 Million USD | -4.08% |
| 2009 | 274.38 Million USD | -6.99% |
| 2008 | 295 Million USD | -11.17% |
| 2007 | 332.1 Million USD | 139.58% |
| 2006 | 138.62 Million USD | 59.59% |
| 2005 | 86.86 Million USD | 0.0% |
| 2003 | 32.34 Million USD | 171.25% |
| 2002 | 11.92 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 468.62 Million USD | -2.21% |
| 2024 Q2 | 476.35 Million USD | -0.1% |
| 2024 Q4 | 468.62 Million USD | 1.32% |
| 2024 Q1 | 476.83 Million USD | -0.5% |
| 2024 Q3 | 462.52 Million USD | -2.9% |
| 2023 FY | 479.21 Million USD | 1.35% |
| 2023 Q1 | 466.34 Million USD | -1.37% |
| 2023 Q2 | 468.76 Million USD | 0.52% |
| 2023 Q3 | 475.72 Million USD | 1.48% |
| 2023 Q4 | 479.21 Million USD | 0.73% |
| 2022 Q4 | 472.84 Million USD | 0.73% |
| 2022 Q1 | 475.77 Million USD | -0.9% |
| 2022 Q2 | 475.5 Million USD | -0.06% |
| 2022 Q3 | 469.43 Million USD | -1.28% |
| 2022 FY | 472.84 Million USD | -1.51% |
| 2021 FY | 480.09 Million USD | -2.04% |
| 2021 Q1 | 464.71 Million USD | -5.18% |
| 2021 Q2 | 478.14 Million USD | 2.89% |
| 2021 Q3 | 486.82 Million USD | 1.82% |
| 2021 Q4 | 480.09 Million USD | -1.38% |
| 2020 Q4 | 490.07 Million USD | 0.02% |
| 2020 FY | 490.07 Million USD | 11.84% |
| 2020 Q1 | 463.74 Million USD | 5.83% |
| 2020 Q2 | 479.47 Million USD | 3.39% |
| 2020 Q3 | 489.98 Million USD | 2.19% |
| 2019 Q4 | 438.18 Million USD | 7.89% |
| 2019 Q1 | 369.13 Million USD | -2.53% |
| 2019 Q3 | 406.13 Million USD | 5.2% |
| 2019 Q2 | 386.07 Million USD | 4.59% |
| 2019 FY | 438.18 Million USD | 15.7% |
| 2018 Q2 | 413.93 Million USD | 5.07% |
| 2018 FY | 378.72 Million USD | -6.82% |
| 2018 Q4 | 378.72 Million USD | -2.22% |
| 2018 Q3 | 387.31 Million USD | -6.43% |
| 2018 Q1 | 393.95 Million USD | -3.08% |
| 2017 FY | 406.46 Million USD | -13.34% |
| 2017 Q4 | 406.46 Million USD | -2.49% |
| 2017 Q3 | 416.84 Million USD | 0.41% |
| 2017 Q1 | 422.73 Million USD | -9.87% |
| 2017 Q2 | 415.16 Million USD | -1.79% |
| 2016 Q1 | 461.8 Million USD | -1.74% |
| 2016 Q3 | 490.02 Million USD | 3.53% |
| 2016 Q4 | 469.03 Million USD | -4.28% |
| 2016 Q2 | 473.32 Million USD | 2.5% |
| 2016 FY | 469.03 Million USD | -0.2% |
| 2015 FY | 469.97 Million USD | -5.09% |
| 2015 Q4 | 469.97 Million USD | 1.36% |
| 2015 Q3 | 463.65 Million USD | -0.84% |
| 2015 Q2 | 467.56 Million USD | 1.72% |
| 2015 Q1 | 459.63 Million USD | -7.18% |
| 2014 Q1 | 473.16 Million USD | -0.58% |
| 2014 Q4 | 495.18 Million USD | 0.84% |
| 2014 Q2 | 485.2 Million USD | 2.55% |
| 2014 Q3 | 491.07 Million USD | 1.21% |
| 2014 FY | 495.18 Million USD | 4.05% |
| 2013 Q2 | 415.63 Million USD | -5.11% |
| 2013 Q3 | 497.07 Million USD | 19.59% |
| 2013 Q4 | 475.92 Million USD | -4.25% |
| 2013 FY | 475.92 Million USD | 0.58% |
| 2013 Q1 | 438.01 Million USD | -7.43% |
| 2012 Q3 | 492.72 Million USD | 0.14% |
| 2012 Q4 | 473.17 Million USD | -3.97% |
| 2012 FY | 473.17 Million USD | 3.81% |
| 2012 Q1 | 500.03 Million USD | 9.71% |
| 2012 Q2 | 492.03 Million USD | -1.6% |
| 2011 FY | 455.78 Million USD | 73.18% |
| 2011 Q4 | 455.78 Million USD | 74.14% |
| 2011 Q3 | 261.72 Million USD | 2.07% |
| 2011 Q2 | 256.42 Million USD | 1.12% |
| 2011 Q1 | 253.58 Million USD | -3.65% |
| 2010 Q1 | 257.62 Million USD | -6.11% |
| 2010 Q2 | 260.51 Million USD | 1.12% |
| 2010 Q3 | 257.97 Million USD | -0.98% |
| 2010 Q4 | 263.18 Million USD | 2.02% |
| 2010 FY | 263.18 Million USD | -4.08% |
| 2009 Q2 | 285.55 Million USD | 1.51% |
| 2009 Q4 | 274.38 Million USD | 0.81% |
| 2009 Q3 | 272.17 Million USD | -4.68% |
| 2009 FY | 274.38 Million USD | -6.99% |
| 2009 Q1 | 281.29 Million USD | -4.65% |
| 2008 Q2 | 310.49 Million USD | -3.06% |
| 2008 Q1 | 320.29 Million USD | -3.56% |
| 2008 Q4 | 295 Million USD | 0.39% |
| 2008 FY | 295 Million USD | -11.17% |
| 2008 Q3 | 293.86 Million USD | -5.36% |
| 2007 Q4 | 332.1 Million USD | 3.45% |
| 2007 Q3 | 321.04 Million USD | 123.38% |
| 2007 FY | 332.1 Million USD | 139.58% |
| 2007 Q1 | 143.52 Million USD | 3.53% |
| 2007 Q2 | 143.72 Million USD | 0.14% |
| 2006 FY | 138.62 Million USD | 59.59% |
| 2006 Q4 | 138.62 Million USD | 0.0% |
| 2005 FY | 86.86 Million USD | 0.0% |
| 2005 Q4 | 86.86 Million USD | 0.0% |
| 2003 FY | 32.34 Million USD | 171.25% |
| 2002 FY | 11.92 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Envoy Medical, Inc. | 7.64 Million USD | -6033.861% |
| Delcath Systems, Inc. | 38.61 Million USD | -1113.651% |
| Xylo Technologies Ltd. | 63.89 Million USD | -633.421% |